What are the different types of testosterone for women?
Have you seen women talking about testosterone on Menopause TikTok and been…
Reduce perimenopause and menopause symptoms with affordable medical care you can access privately online.
Medications require consultation with a licensed QuickMD doctor, who determines treatment eligibility. QuickMD recommends menopause hormone therapy patients get a mammogram at least every two years. Those with a personal or family history of breast cancer should consult their doctor before starting treatment.
Pay $79 per visit. No subscription. No commitments.
Talk to a doctor who understands what your body’s going through. Get guidance and answers now.
Get safe, effective treatments that actually help you feel better, including testosterone with proper testing when appropriate.
Book a visit, get treated fast, and have your medication delivered straight to your door with free 2-day shipping.
Work with a doctor who listens and gets it. No more feeling dismissed or figuring it out alone.
Hormone therapy, with estrogen alone or combined with progesterone, has been shown in clinical trials to reduce hot flashes and night sweats by about 75%. It’s considered the most effective treatment for these symptoms and can improve your quality of life during menopause.*
*A 2023 JAMA review found systemic estrogen therapy, alone or with progesterone, cut hot flashes and night sweats by ~75%. The North American Menopause Society confirms hormone therapy is the most effective option, especially for women under 60 or within 10 years of menopause.
Proven medications at an affordable price, delivered right to your door.
You may qualify for hormone therapy if you are experiencing moderate to severe menopausal symptoms that disrupt daily life. These symptoms can include hot flashes, night sweats, insomnia, mood changes, vaginal dryness, irregular bleeding, or memory and concentration difficulties.
Eligibility also depends on your overall health and medical history. For example, women without a uterus may be prescribed estrogen-only therapy, while those with a uterus require combined estrogen and progesterone therapy to protect the uterine lining from overgrowth.
When starting hormone therapy, doctors usually recommend a comprehensive evaluation, including blood tests (CBC, CMP, lipid panel, thyroid, Vitamin D, and others) to tailor the safest treatment plan. Ultimately, whether you qualify depends on a discussion with your healthcare provider, balancing your symptoms, risks, and personal health goals.
Yes. Menopause hormone therapy (MHT) is considered safe for most healthy women, especially if started within 10 years of menopause or before age 60. Earlier studies in the early 2000s raised concerns about risks, but more recent evidence shows that the benefits often outweigh risks when therapy is personalized. For low-risk women, MHT can safely:
However, MHT is not for everyone. Women with a personal history of breast, ovarian, or endometrial cancer, a strong family history of breast cancer, a history of blood clots, stroke, heart disease, liver disease, or untreated high blood pressure should not take MHT. Long-term use beyond age 60 can be appropriate in some cases, with regular monitoring (mammograms, colon screenings). Safety comes from therapy that is individualized, closely monitored, and reassessed yearly with your provider.
Hormone therapy works by replacing the estrogen (and sometimes progesterone and testosterone) that the body no longer produces after menopause. This helps restore balance and relieve symptoms caused by fluctuating or depleted hormone levels.
Specifically, MHT:
Estrogen can be delivered through oral tablets, skin patches, creams, gels, sprays, or vaginal rings. Progesterone is added if you still have a uterus to prevent uterine lining complications. In some cases, testosterone may also be prescribed to help with libido, energy, or muscle health.
In short, MHT targets the root hormonal imbalance of menopause, not just the symptoms, making it one of the most effective treatments available.